Nodal Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India launches SARS-CoV-2 Genomic Consortium to monitor viral mutations India launches SARS-CoV-2 Genomic Consortium to monitor viral mutations 31 December 2020 | News The consortium will ascertain the status of new variant of SARS-CoV-2 (SARS-CoV-2 VUI 202012/01) in the country and establish a sentinel surveillance for early detection of genomic variants with public health implication. Source credit: Shutterstock The government has launched the Indian SARS-CoV-2 Genomic Consortia (INSACOG), comprising 10 labs namely DBT-NIBMG Kalyani, DBT-ILS Bhubaneswar, ICMR-NIV Pune, DBT-NCCS Pu...

Vaccines which are in pipeline will work against the new variants of SARS-CoV-2 India Published: Wednesday, December 30, 2020, 11:17 [IST] New Delhi, Dec 30: In a major development this week, Indian SARS-CoV-2 Genomics Consortium (INSACOG) has been formed with 10 Government laboratories to ascertain the current status of new variant of SARS-CoV-2 (SARS-CoV-2 VUI 202012/01) in the country. Its function is also to establish a sentinel surveillance for early detection of genomic variants with public health implication and to determine the genomic variants in the unusual events/trends. This apart...

Updated Dec 28, 2020 | 13:22 IST The overall aim of the proposed Indian SARS-CoV-2 Genomics Consortium (INSACOG) is to monitor the genomic variations in the COVID-19 on a regular basis through a multi-laboratory network. Representational Image  |  Photo Credit: PTI New Delhi: In view of the new strain of COVID-19 detected in the United Kingdom, the Central government has formed a genomic surveillance consortium for laboratory and epidemiological surveillance of circulating strains of the SARS-CoV-2 in India. The genomic surveillance consortium, INSACOG, has ...